Friday, July 19, 2013

Peter Aluani - Akupunktur und Lasertherapie bei chronischen Schmerzen




Videos





Peter Aluani - Akupunktur und Lasertherapie bei chronischen Schmerzen









Peter Aluani hält einen Vortrag über "Akupunktur und Lasertherapie bei chronischen Schmerzen". Weitere Infos finden Sie unter: http://videocenter.naturmed.de.

Views:
0


0
ratings
Time:
05:16
More in
Education








Videos





Reflexology in Kent | from Into the Blue Gift Vouchers









Enjoy relaxing Reflexology In Kent! Sarah is a fully qualified reflexologist who studied at the Central London College of Reflexology and now has practices i...

Views:
0


0
ratings
Time:
00:31
More in
Entertainment








HubMed - Low Level Laser therapy





Effects of biosilicate(®) scaffolds and low-level laser therapy on the process of bone healing.



Photomed Laser Surg. 2013 Jun; 31(6): 252-60
Pinto KN, Tim CR, Crovace MC, Matsumoto MA, Parizotto NA, Zanotto ED, Peitl O, Rennó AC

Abstract Objective: This study aimed to investigate the in vivo tissue performance of the association of Biosilicate(®) scaffolds and low-level laser therapy (LLLT) in a tibial bone defects model in rats. Background data: Many studies have been demonstrating the osteogenic potential of Biosilicate and LLLT. However, there is a need to investigate the effects of both treatments for bone consolidation. Methods: The animals were divided into control group (CG), Biosilicate scaffold group (BG), and Biosilicate scaffolds plus LLLT group (BLG). Animals were euthanized after 15, 30, and 45 days post-injury. Results: The histological analysis revealed that all the experimental groups showed inflammatory infiltrate and granulation tissue, at the area of the defect at day 15. After 30 days, CG still showed granulation tissue and bone ingrowth. Both Biosilicate groups presented newly formed bone and interconected trabeculae. At 45 days, CG showed immature newly formed bone. A more mature newly formed bone was observed in BG and BLG. On day 15, BG demonstrated a statistically higher expression of cyclooxygenase (COX)-2 compared with CG and BLG. No statistically significant difference was observed in COX-2 immunoexpression among the groups at 30 and 45 days. Similar expression of bone morphogenetic protein (BMP)-9 was demonstrated for all experimental groups at 15 and 30 days. At 45 days, the BMP-9 immunoexpression was statistically upregulated in the BLG compared with the CG and BG. No statistically significant difference was observed in the receptor activator of nuclear factor kappa-B ligand (RANKL) immunoexpression among the groups in all periods evaluated. Biosilicate groups presented a decrease in biomechanical properties compared with CG at 30 and 45 days post-surgery. Conclusions: Our findings suggest that Biosilicate presented osteogenic activity, accelerating bone repair. However, laser therapy was not able to enhance the bioactive properties of the Biosilicate.







No comments: